Pharmacoepidemiology of testosterone prescribing in Australia, 2010-2023.
OBJECTIVE After decades of progressive increase, subsidized testosterone prescribing under the Pharmaceutical Benefits Scheme (PBS) in Australia reduced following tightening of prescribing criteria in 2015. Conversely, testosterone use as gender-affirming hormone therapy (GAHT) for transgender and gender-diverse indivi...